Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.

Anita BálintMariann RutkaZsuzsanna VéghZsuzsanna KürtiKrisztina B GecseJános BanaiLászló BeneBeáta GasztonyiTünde KristófLászló LakatosPál MihellerKároly PalatkaÁrpád PataiÁgnes SalamonTamás SzamosiZoltán SzepesGábor Tamás TóthÁron VinczeRenáta BorÁgnes MilassinAnna FábiánFerenc NagyMartin KolarMartin BortlikDana DuricovaVeronika HrubaMartin LukasKatarina MitrovaKarin MalickovaMilan LukasPéter L LakatosTamás MolnárKlaudia Farkas

Published in: Expert opinion on drug safety (2017)

Patients with previous exposure to anti-TNF-alpha and ADA positivity during the induction therapy were more likely to develop infusion reactions.

Keyphrases

low dose
rheumatoid arthritis
cross sectional
stem cells
cell therapy
smoking cessation